The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation
Abstract
In the kidney, conversion of cortisol to cortisone by the enzyme 11 beta-hydroxysteroid dehydrogenase protects mineralocorticoid receptors from cortisol. In the liver, a different isoform of the enzyme favors 11 beta-reductase conversion of cortisone to cortisol. We have tested the hypothesis that hepatic 11 beta-reductase enhances glucocorticoid receptor activation in the liver by inhibiting the enzyme with carbenoxolone and observing effects on insulin sensitivity. Seven healthy males took part in a double blind randomized cross-over study in which oral carbenoxolone (100 mg every 8 h) or placebo was administered for 7 days. Euglycemic hyperinsulinemic clamp studies were then performed, including measurement of forearm glucose uptake. Carbenoxolone increased whole body insulin sensitivity (M values for dextrose infusion rates, 41.1 +/- 2.4 mumol/kg.min for placebo vs. 44.6 +/- 2.3 for carbenoxolone; P < 0.03), but had no effect on forearm insulin sensitivity. We infer that carbenoxolone, by inhibiting hepatic 11 beta-reductase and reducing intrahepatic cortisol concentration, increases hepatic insulin sensitivity and decreases glucose production. Thus, plasma cortisone provides an inactive pool that can be converted to active glucocorticoids at sites where 11 beta-reductase is expressed, abnormal hepatic 11 beta-reductase activity might be important in syndromes of insulin resistance, and manipulation of hepatic 11 beta-reductase may be useful in treating insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
The measurement of volume changes in human limbs
Whitney, R. J. (1953) · The Journal of Physiology · doi:10.1113/jphysiol.1953.sp004926 · Cited by 1,489
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., & Olefsky, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 926
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
ULICK, S., KODAMA, T., GUNCZIER, P., ZANCONATO, G., RAMIREZ, L. C., RAUH, W., ROSLER, A., BRADLOW, H. L., & NEW, M. I. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-5-757 · Cited by 496
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase
Agarwal, A. K., Monder, C., Eckstein, B., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47248-7 · Cited by 455
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells
Rusvai, E., & Náray-Fejes-Tóth, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82044-0 · Cited by 248
Agarwal, A. K., Mune, T., Monder, C., & White, P. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47142-6 · Cited by 246
Gerich, J. E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80207-1 · Cited by 224
Rodin, A., Thakkar, H., Taylor, N., & Clayton, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402173300703 · Cited by 192
Stewart, P. M., Wallace, A. M., Atherden, S. M., Shearing, C. H., & Edwards, C. R. W. (1990) · Clinical Science · doi:10.1042/cs0780049 · Cited by 187
Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
Dinneen, S., Alzaid, A., Miles, J., & Rizza, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116832 · Cited by 175
Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension
Walker, B. R., Stewart, P. M., Shackleton, C. H. L., Padfield, P. L., & Edwards, C. R. W. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01778.x · Cited by 174
Self-citationWalker, B. R., Campbell, J. C., Fraser, R., Stewart, P. M., & Edwards, C. R. W. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01478.x · Cited by 170
Self-citationMechanisms of dexamethasone-induced insulin resistance in healthy humans
Tappy, L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.4.1063 · Cited by 166
Soro, A., Ingram, M. C., Tonolo, G., Glorioso, N., & Fraser, R. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.67 · Cited by 164
AFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
Armanini, D., Karbowiak, I., & Funder, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 163
Licorice-Induced Hypertension and Syndromes of Apparent Mineralocorticoid Excess
Walker, B. R., & Edwards, C. R. W. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30102-6 · Cited by 159
Self-citationEffect of sodium intake on insulin sensitivity
Donovan, D. S., Solomon, C. G., Seely, E. W., Williams, G. H., & Simonson, D. C. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.5.e730 · Cited by 138
Contribution of cortisol to glucose counterregulation in humans
De Feo, P., Perriello, G., Torlone, E., Ventura, M. M., Fanelli, C., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.1.e35 · Cited by 134
Walker, B. R., Connacher, A. A., Webb, D. J., & Edwards, C. R. W. (1992) · Clinical Science · doi:10.1042/cs0830171 · Cited by 124
Self-citationWalker, B. R., Campbell, J. C., Williams, B. C., & Edwards, C. R. W. (1992) · Endocrinology · doi:10.1210/endo.131.2.1639034 · Cited by 96
Self-citationMimura, K., Umeda, F., Hiramatsu, S., Taniguchi, S., Ono, Y., Nakashima, N., Kobayashi, K., Masakado, M., Yoshiyasu, S. A. K. O., & Nawata, H. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00333.x · Cited by 87
The effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin action.
Rooney, D. P., Neely, R. D., Cullen, C., Ennis, C. N., Sheridan, B., Atkinson, A. B., Trimble, E. R., & Bell, P. M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077310 · Cited by 76
Weaver, J. U., Kopelman, P. G., McLoughlin, L., Forslingt, M. L., & Grossman, A. B. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02375.x · Cited by 65
Duperrex, H., Kenouch, S., Gaeggeler, H. P., Seckl, J. R., Edwards, C. R. W., Farman, N., & Rossier, B. C. (1993) · Endocrinology · doi:10.1210/endo.132.2.8425481 · Cited by 57
Féry, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.3.8126123 · Cited by 54
Stewart, P. M., & Sheppard, M. C. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90149-z · Cited by 47
New Pharmacological Approaches to Insulin and Lipid Metabolism
Petrie, J. R., & Donnelly, R. (1994) · Drugs · doi:10.2165/00003495-199447050-00001 · Cited by 15
Cited by
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“decreases hepatic glucose production (199).”
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Metadata
- Authors
- Walker, B. R.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1995-11-01
- Volume
- 80
- Issue
- 11
- Pages
- 3155-3159
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1986842715
- Cited by
- 277
- References
- 33
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.